Junli Wu

2.6k total citations
93 papers, 2.0k citations indexed

About

Junli Wu is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Junli Wu has authored 93 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Oncology, 26 papers in Surgery and 15 papers in Molecular Biology. Recurrent topics in Junli Wu's work include Pancreatic and Hepatic Oncology Research (39 papers), Pancreatitis Pathology and Treatment (15 papers) and Neuroendocrine Tumor Research Advances (12 papers). Junli Wu is often cited by papers focused on Pancreatic and Hepatic Oncology Research (39 papers), Pancreatitis Pathology and Treatment (15 papers) and Neuroendocrine Tumor Research Advances (12 papers). Junli Wu collaborates with scholars based in China, United States and United Kingdom. Junli Wu's co-authors include Peng Shi, Huijun Gao, Yi Miao, Kuirong Jiang, Wentao Gao, Jishu Wei, Yunpeng Peng, Zekuan Xu, Gang Hu and Yi Zhu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and Scientific Reports.

In The Last Decade

Junli Wu

87 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junli Wu China 25 781 456 321 308 272 93 2.0k
Dongguang Li China 21 1.1k 1.4× 498 1.1× 95 0.3× 333 1.1× 1.1k 4.0× 96 2.8k
Seongjoon Park South Korea 25 456 0.6× 600 1.3× 377 1.2× 30 0.1× 77 0.3× 88 2.2k
Jinjun Rao China 17 608 0.8× 947 2.1× 171 0.5× 96 0.3× 240 0.9× 76 2.2k
HyungJun Cho South Korea 25 596 0.8× 700 1.5× 570 1.8× 28 0.1× 190 0.7× 129 2.3k
Eun‐Jong Cha South Korea 20 117 0.1× 442 1.0× 638 2.0× 386 1.3× 62 0.2× 72 1.9k
Sihua Wang China 25 223 0.3× 500 1.1× 139 0.4× 26 0.1× 281 1.0× 101 1.9k
Nan Ji China 29 266 0.3× 715 1.6× 149 0.5× 81 0.3× 205 0.8× 193 2.7k
Michele Russo Italy 23 165 0.2× 228 0.5× 231 0.7× 149 0.5× 106 0.4× 98 1.6k
Zhengjie Huang China 25 460 0.6× 887 1.9× 144 0.4× 26 0.1× 212 0.8× 90 2.3k
Tao Peng China 28 368 0.5× 1.8k 4.0× 266 0.8× 34 0.1× 213 0.8× 104 2.8k

Countries citing papers authored by Junli Wu

Since Specialization
Citations

This map shows the geographic impact of Junli Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junli Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junli Wu more than expected).

Fields of papers citing papers by Junli Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junli Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junli Wu. The network helps show where Junli Wu may publish in the future.

Co-authorship network of co-authors of Junli Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Junli Wu. A scholar is included among the top collaborators of Junli Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junli Wu. Junli Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Feng, Wenjun, et al.. (2024). Profiling volatile compounds in fresh leaves of 22 major oolong tea germplasm cultivated in Fujian of China. Scientia Horticulturae. 327. 112849–112849. 15 indexed citations
3.
Xu, Guoxiao, et al.. (2023). Recent Approaches to Achieve High Temperature Operation of Nafion Membranes. Energies. 16(4). 1565–1565. 31 indexed citations
4.
Lu, Zipeng, Qiang Li, Kuirong Jiang, et al.. (2023). A Risk Score for Predicting the Necessity of Surgical Necrosectomy in the Treatment of Infected Necrotizing Pancreatitis. Journal of Gastrointestinal Surgery. 27(10). 2145–2154. 4 indexed citations
6.
Yin, Lingdi, Yichao Lu, Cheng Cao, et al.. (2022). CA9-Related Acidic Microenvironment Mediates CD8+ T Cell Related Immunosuppression in Pancreatic Cancer. Frontiers in Oncology. 11. 832315–832315. 23 indexed citations
7.
Li, Qiang, Zipeng Lu, Kuirong Jiang, et al.. (2021). From “step-up” to “step-jump”: a leap-forward intervention for infected necrotizing pancreatitis. Chinese Medical Journal. 135(3). 285–287. 7 indexed citations
8.
Wu, Junli, et al.. (2021). Efficacy comparison of optimal treatments for hepatocellular carcinoma patients with portal vein tumor thrombus. Annals of Hepatology. 27(1). 100552–100552. 12 indexed citations
9.
Huang, Shimeng, Kai Zhang, Junli Wu, et al.. (2020). Evaluation of Twenty-One Cases of Abdominal Tuberculosis: A Single-Center Experience. Surgical Infections. 22(3). 299–304. 3 indexed citations
10.
Cai, Baobao, Feng Guo, Junli Wu, et al.. (2019). Parenchyma Preserving Surgery for Idiopathic Chronic Calcific Pancreatitis in Children: A Report of Three Cases. SHILAP Revista de lepidopterología. 5(1). 51–57. 2 indexed citations
11.
Gao, Hao, Guangfu Wang, Yong Gao, et al.. (2019). Central pancreatectomy for early-stage pancreatic ductal adenocarcinoma: a single-center case–control study. Langenbeck s Archives of Surgery. 404(2). 175–182. 13 indexed citations
12.
Wei, Jishu, Xujun Song, Xinchun Liu, et al.. (2018). Glucagonoma and Glucagonoma Syndrome: One Center's Experience of Six Cases. SHILAP Revista de lepidopterología. 4(1). 11–16. 12 indexed citations
13.
Lu, Zipeng, Jie Yin, Jishu Wei, et al.. (2016). Small amounts of tissue preserve pancreatic function. Medicine. 95(46). e5274–e5274. 3 indexed citations
14.
Wei, Jishu, Shibo Lin, Cong Wang, et al.. (2015). Glucagonoma syndrome: A case report. Oncology Letters. 10(2). 1113–1116. 11 indexed citations
15.
Zhang, Jingjing, Yiyi Zhu, Kun-Ling Xie, et al.. (2014). Yin Yang-1 suppresses invasion and metastasis of pancreatic ductal adenocarcinoma by downregulating MMP10 in a MUC4/ErbB2/p38/MEF2C-dependent mechanism. Molecular Cancer. 13(1). 130–130. 94 indexed citations
16.
Peng, Yunpeng, Jingjing Zhang, Wenbiao Liang, et al.. (2014). Elevation of MMP-9 and IDO induced by pancreatic cancer cells mediates natural killer cell dysfunction. BMC Cancer. 14(1). 738–738. 75 indexed citations
17.
Peng, Yunpeng, Yi Zhu, Jingjing Zhang, et al.. (2013). Comprehensive analysis of the percentage of surface receptors and cytotoxic granules positive natural killer cells in patients with pancreatic cancer, gastric cancer, and colorectal cancer. Journal of Translational Medicine. 11(1). 262–262. 138 indexed citations
18.
Li, Qiang, Yong An, Nan Lv, et al.. (2013). CEACAM6 induces epithelial-mesenchymal transition and mediates invasion and metastasis in pancreatic cancer. International Journal of Oncology. 43(3). 877–885. 47 indexed citations
19.
Wu, Junli, et al.. (2011). Rheology and processability of polyamide66 filled with different‐sized and size‐distributed calcium carbonate. Polymer Composites. 32(10). 1633–1639. 4 indexed citations
20.
Wu, Junli, Jishu Wei, Kai Meng, et al.. (2009). Identification of an HLA-A*0201-restrictive CTL epitope from MUC4 for applicable vaccine therapy. Immunopharmacology and Immunotoxicology. 31(3). 468–476. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026